Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
References: MHRA/EMC Summary of Product Characteristics: Mounjaro (tirzepatide) EMA European Public Assessment Report: Mounjaro (tirzepatide) Mounjaro (tirzepatide) is a dual GIP and GLP-1 receptor agonist, a peptide-based medication that mimics naturally occurring gut hormones to regulate appetite and blood glucose levels
Within the NHS, NICE guidance typically recommends treatment with Wegovy through specialist weight management services for up to 2 years
They are especially useful for polycystic ovary syndrome (PCOS) and infertility linked to obesity
Tirzepatide targets GLP-1 and GIP, enhancing appetite control and weight loss
US$ 22.65
US$ 28.32
US$ 29.28
US$ 22.38
